Cross Icon
Let’s talk.
Let’s talk about
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

WeGuide alternatives: compare 31 clinical research platforms (2026)

WeGuide is the patient-first clinical research platform that replaces three to five stitched tools with one, configured alongside your team in weeks rather than months. Whether you're outgrowing REDCap, frustrated with OpenClinica's setup, or evaluating enterprise platforms like Medidata, Veeva, Oracle, IQVIA, or Clario, this hub walks through how WeGuide compares across every dimension that matters.

No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours. Cancel anytime, no commitment.

Used by leading research and medical institutes.

Why research teams compare clinical trial platforms

Platform choice has a compounding effect on a study. The right fit reduces implementation weeks, lifts participant adherence, and removes the procurement friction of stitching five tools together.

Most evaluations land on one of three questions:

"We're outgrowing REDCap or OpenClinica." You need eCOA, eConsent, wearables, and a participant mobile app that open-source tools weren't built for.

"We're priced out of Medidata, Veeva, Oracle, or Medable." Enterprise platforms bill at six and seven figures with 3-to-6-month implementations. Mid-market research budgets don't absorb that.

"We need a technology platform, not a CRO services contract." IQVIA, Science 37, Thread, and ObvioHealth bundle services with the platform. For teams that own study operations or already work with a CRO, a pure technology platform is a cleaner fit.

WeGuide sits in a specific place in this market: a patient-first clinical research platform with whitelabel mobile apps, native wearable integration, and a library of validated instruments, priced for mid-market sponsors, academic research, CROs, and health organisations. It isn't a replacement for every platform below, and we'll say so wherever it's true.

Why WeGuide wins when it's the right fit

When the use case matches, here's what changes for research teams who move to WeGuide.

Engagement that keeps participants in the study

Push notifications, in app messaging, education content and gamification keep participants engaged between visits. The BRACE trial, an international hybrid trial run with Murdoch Children's Research Institute, used WeGuide with thousands of participants across several countries. Validated instruments and whitelabel apps do the heavy lifting for data quality and retention.

Configured in weeks, not months

Enterprise platforms measure implementation in months; WeGuide measures in weeks. Our no-code Form Builder allows research coordinators to configure studies directly rather than handing technical specs to a services team. This significantly reduces lead times and allows for rapid protocol adjustments.

One platform, not five stitched tools

eCOA, eConsent, telehealth, wearables, and registries all sit inside one platform in the core licence. Our Integration Engine connects to external EDCs like Rave, Vault, or REDCap where you need them. There are no add-on modules and no complex per-feature pricing tiers to navigate.
‍

Compliance built in from day one

TGA registered Class I medical device software (ARTG 355337), ISO 27001:2022 certified, and supports HIPAA, GDPR and 21 CFR Part 11 requirements. Australian data residency is a first-class offering for APAC sponsors. WeGuide provides a secure, audited environment that meets the rigorous regulatory demands of global academic and clinical research.

All comparisons

Find the comparison you need

Filter by the kind of platform you are weighing up. Each page sets out where WeGuide fits, where the other platform is stronger, and how a move works.

User case

WeGuide across every research use case

Use case
What WeGuide delivers
Proof
Clinical trials
End-to-end trial management with EDC integration, eConsent, ePRO, eCOA, automated workflows
BRACE trial: international hybrid trial with Murdoch Children's Research Institute
Patient registries
Purpose built registry with longitudinal data collection and participant engagement
FSHD Global Registry: rare disease longitudinal registry
Decentralised clinical trials
Remote data collection, whitelabel apps, wearable integration, telehealth
Multiple DCT deployments during COVID-19
Real world evidence
Passive wearable data plus ePRO from participants' own devices
Native Garmin, Apple Health, Health Connect and Fitbit Air integrations
Population health
Large scale cohort studies with multilingual support
GenV: roughly 124,000 Victorians
Employee wellbeing
Workplace health programmes with validated instruments
Lendlease digital therapy programme
Citizen science and multilingual community research
Dynamic translation management, culturally adapted content
INHERIT: multilingual community research during COVID-19
Paediatric cardiac monitoring
Apple Watch plus wearable data, paediatric-friendly UX
Beat2Beat paediatric heart rhythm study

Case studies: research at scale

BRACE Trial (Murdoch Children's Research Institute)

An international randomised trial testing whether the BCG vaccine could protect healthcare workers during COVID-19, run across several countries with thousands of participants. It was a hybrid design: vaccination and blood collection happened in person, and WeGuide supported the participant facing side of the study between those site contacts.

Learn more

GenV (Generation Victoria)

A whole of state longitudinal birth cohort covering roughly 124,000 Victorians: about 50,000 children and 74,000 parents. Longitudinal data collection, multi-year participant relationships, and a family-branded whitelabel app. Registry work that most DCT-focused competitors don't offer natively.

Learn more

FSHD Global Registry

A rare disease patient registry for facioscapulohumeral muscular dystrophy, running globally with longitudinal participant engagement. Another registry use case outside DCT-only competitors' scope.

Learn more

Hear what our clients have to say!

"WeGuide has transformed how we engage with our community. The platform made it simple to launch our air quality monitoring study across 15 neighborhoods in just three weeks."
Susan Clifford
Susan Clifford
Senior Research Officer
GEN V logo
“The multilingual support was game-changing. We reached citizens who were previously excluded from research opportunities, resulting in a truly representative dataset.”
Testimonial Logo
Kaya Gardiner
Trial Project Manager
Murdoch children Research Institute
"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."
Emma Photo
Emma Weatherley
Managing Director
FSHD Global
"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."
KATE Cranwell
Kate Cranwell
Manager
Western Health
"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."
Testimonial Photo
Paul Eleftheriou
Chief Medical Officer
Western Health

Frequently asked questions

Straight answers on how WeGuide compares across the major clinical trial platforms.

Contact us

How does WeGuide compare to REDCap?

REDCap is free and excellent for academic survey research with 7,000+ institutions. WeGuide adds a whitelabel participant mobile app, native wearable integration (Garmin, Apple Health, Health Connect and Fitbit Air), built-in eConsent with version control, TGA registered Class I medical device software, and multilingual translation management. For studies that need engagement, eCOA, eConsent, or wearables, WeGuide extends beyond REDCap's academic survey scope. For pure data collection on a zero-dollar budget with institutional IT support, REDCap is still a strong choice and we'll say so. See the full REDCap comparison →

How does WeGuide compare to OpenClinica?

OpenClinica is an EDC first open source platform with strong eCRF design and edit check capability. WeGuide is patient-first, with EDC available via Integration Engine rather than natively. The two are complementary for studies that combine deep EDC requirements with participant engagement. For pure site-based EDC with eCRFs, OpenClinica is hard to beat. For ePRO, eConsent, wearables, patient registries, or employee wellbeing, WeGuide covers the ground OpenClinica doesn't.

Which platforms support native wearable data collection?

WeGuide integrates natively with Garmin, Apple Health, Health Connect and Fitbit Air, and collects raw accelerometer and gyroscope data at 25 Hz from supported Garmin models. Most competitors (Medable, Medidata, Veeva, Oracle, Thread, ObvioHealth) support wearables via partner integrations or connected device layers. Clario provisions validated devices rather than supporting BYOD wearables. WeGuide supports both participants' own devices and devices the sponsor provides.

Is WeGuide TGA registered, and does it support FDA 21 CFR Part 11 requirements?

Yes. WeGuide is TGA registered Class I medical device software (ARTG 355337), is ISO 27001:2022 certified, and supports FDA 21 CFR Part 11, HIPAA and GDPR requirements. Australian data residency is a first-class offering for APAC sponsors and academic research.

How quickly can I deploy a study with WeGuide?

Configuration alongside your team typically takes two to four weeks after the discovery call, followed by launch and a named delivery contact. Enterprise platforms (Medidata, Veeva, Oracle, Medable) typically measure implementation in three to six months with a services engagement. The no code Form Builder lets research coordinators configure studies directly rather than handing specs to a services team.

Can WeGuide handle multilingual studies?

Yes. INHERIT used WeGuide's dynamic translation management and culturally adapted content for multilingual community research during COVID-19. Multilingual translation management is built into the platform rather than requiring per language survey configuration.

Does WeGuide integrate with existing EDCs?

Yes. Integration Engine connects to Medidata Rave, Veeva Vault, REDCap, Viedoc, Clinion, Oracle InForm, and custom EDCs. For sponsors who already have an EDC preference or want flexibility, WeGuide runs alongside rather than replacing. Many teams pair WeGuide (participant-facing) with their existing EDC (data management).

How does pricing compare across clinical trial platforms?

Enterprise platforms (Medidata, Veeva, Oracle, Medable, Clario, IQVIA) bill at six and seven figures with multi year contracts, often bundled with services. Services led platforms (Science 37, ObvioHealth, Thread) bundle virtual CRO or consulting scope into the quote. WeGuide is technology only project-based pricing with every module included in the core licence, priced accessibly for mid market sponsors, academic research, and CROs. REDCap and OpenClinica community edition are free but require institutional IT to run.

See how WeGuide fits your study.

A 30 minute walkthrough with a research colleague, focused on your protocol, your participants and the tools you already run.

Book a demo